Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma

<div>Expression profile of miR-101 and miR-125b from TCGA. (a) miR-101 was downregulated in liver hepatocellular carcinoma tissues compared with normal tissues. (b) miR-125b was downregulated in liver hepatocellular carcinoma tissues compared with normal tissues. Abbreviations: LIHC: liver hepatocellular carcinoma.</div>

International Journal of Genomics

fig5

Figure 5

Figure 5: Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma 